| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology, Leiden University Medical Center (N.R.B., S.W.v.T., A.M.P., H.C.H., J.W.A.S., J.A.R., F.R.), 2333 ZA Leiden, The Netherlands; and Parnassia Psychomedical Center (A.M.v.H.), 2553 RJ The Hague, The Netherlands
Address all correspondence and requests for reprints to: Dr. N. R. Biermasz, Department of Endocrinology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: nrbiermasz{at}lumc.nl.
The long-term impact of acromegaly on subjective well-being after treatment of GH excess is unclear. Therefore, we evaluated quality of life by validated questionnaires in a cross-sectional study of 118 successfully treated acromegalic patients. The initial treatment was transsphenoidal surgery in most patients (92%), if necessary followed by radiotherapy or octreotide. All patients were in remission at the time of assessment (GH, <1.9 µg/liter; normal IGF-I for age). General perceived well-being was reduced compared with controls for all subscales (P < 0.001) as measured by the Nottingham Health Profile and the Short Form-36. Acromegalic patients also had lower scores on fatigue (Multidimensional Fatigue Index) and anxiety and depression (Hospital Anxiety and Depression Scale). Radiotherapy was associated with decreased quality of life in all subscales except for the Hospital Anxiety and Depression Scale, and worsened quality of life significantly, according to the fatigue scores. Somatostatin analog treatment was not associated with improved quality of life. Independent predictors of quality of life were age (physical subscales and Nottingham Health Profile), disease duration (social isolation and personal relations), and radiotherapy (physical and fatigue subscales). In conclusion, patients cured after treatment for acromegaly have a persistently decreased quality of life despite long-term biochemical cure of GH excess. Radiotherapy especially is associated with a reduced quality of life.
This article has been cited by other articles:
 |
|
 |
|
  S M Webb, X Badia, M J Barahona, A Colao, C J Strasburger, A Tabarin, M O van Aken, R Pivonello, G Stalla, S W J Lamberts, et al. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire Eur. J. Endocrinol., May 1, 2008; 158(5): 623 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, and P. Caron Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance Eur. J. Endocrinol., March 1, 2008; 158(3): 305 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Havekes, A A van der Klaauw, H C Hoftijzer, J C Jansen, A G L van der Mey, A H J T Vriends, J W A Smit, J A Romijn, and E P M Corssmit Reduced quality of life in patients with head-and-neck paragangliomas Eur. J. Endocrinol., February 1, 2008; 158(2): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Dekkers, N. R. Biermasz, A. M. Pereira, J. A. Romijn, and J. P. Vandenbroucke Mortality in Acromegaly: A Metaanalysis J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Hoftijzer, K. A. Heemstra, E. P. M. Corssmit, A. A. van der Klaauw, J. A. Romijn, and J. W. A. Smit Quality of Life in Cured Patients with Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 200 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T'Sjoen, M. Bex, D. Maiter, B. Velkeniers, and R. Abs Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian Registry on acromegaly Eur. J. Endocrinol., October 1, 2007; 157(4): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Kars, A A van der Klaauw, C S Onstein, A M Pereira, and J A Romijn Quality of life is decreased in female patients treated for microprolactinoma Eur. J. Endocrinol., August 1, 2007; 157(2): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kauppinen-Makelin, T. Sane, H. Sintonen, H. Markkanen, M. J. Valimaki, E. Loyttyniemi, L. Niskanen, A. Reunanen, U.-H. Stenman, and and the Finnish Acromegaly Study Group Quality of Life in Treated Patients with Acromegaly J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3891 - 3896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Dekkers, A. A. van der Klaauw, A. M. Pereira, N. R. Biermasz, P. J. Honkoop, F. Roelfsema, J. W. A. Smit, and J. A. Romijn Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3364 - 3369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M Webb, X. Badia, and Nuria Lara Surinach for the Spanish AcroQoL Study Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur. J. Endocrinol., August 1, 2006; 155(2): 269 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O M Dekkers, N R Biermasz, J W A Smit, L E Groot, F Roelfsema, J A Romijn, and A M Pereira Quality of life in treated adult craniopharyngioma patients. Eur. J. Endocrinol., March 1, 2006; 154(3): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Biermasz, A. M. Pereira, J. W. A. Smit, J. A. Romijn, and F. Roelfsema Morbidity after Long-Term Remission for Acromegaly: Persisting Joint-Related Complaints Cause Reduced Quality of Life J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2731 - 2739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R Biermasz, N. A T Hamdy, A. M Pereira, J. A Romijn, and F. Roelfsema Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly Eur. J. Endocrinol., January 1, 2005; 152(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
